Purification and characterization of butyrate-induced protein phosphatase involved in apoptosis of Ehrlich ascites tumor cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 1, 2007, Pages 39-47

  Belakavadi, Madesh ^a   Prabhakar, B T ^a   Salimath, Bharathi P ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Apoptosis; Butyrate; Caspase 3; EAT cell; Endonuclease II; Protein phosphatase

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE; VANADATE SODIUM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; EHRLICH ASCITES TUMOR CELL; ENZYME ACTIVATION; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BUTYRATES; CARCINOMA, EHRLICH TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; PHOSPHOPROTEIN PHOSPHATASE; VANADATES;

EID: 33845460308     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.07.007     Document Type: Article

References (51)

1. Hunter T. Signaling-2000 and beyond. Cell 100 (2000) 113-127
2. Sim A.T., and Scott J.D. Targeting PKA, PKC and protein phosphatases to cellular microdomains. Cell Calcium 26 (1999) 209-217
3. Bridges A.J. Chemical inhibitors of protein kinases. Chem. Rev. 101 (2001) 2541-2572
4. Noble M.E.M. Protein kinases inhibitors: insights into drug design from structure. Science 303 (2004) 1800-1805
5. Grosios K., and Traxler P. Tyrosine kinase targets in drug discovery. Drugs Future 28 (2003) 679-697
6. Shawver L.K., Slamon D., and Ullrich A. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1 (2002) 117-123
7. Freiss G., and Vignon F. Protein tyrosine phosphatases and breast cancer. Crit. Rev. Oncol./Hematol. 52 (2004) 9-17
8. Barnekow A., and Gessler M. Activation of the pp60c-src kinase during differentiation of monomyelocytic cells in vitro. EMBO J. 5 (1986) 701-705
9. Naftilan A.J., Gilliland G.K., Eldridge C.S., and Kraft A.S. Induction of the proto-oncogene c-jun by angiotensin II. Mol. Cell. Biol. 11 (1990) 5536-5540
10. Hague A., Manning A.M., Hanlon K.A., Huschtscha L.I., Hart D., and Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fiber in the prevention of large-bowel cancer. Int. J. Cancer 55 (1993) 498-505
11. Heerdt B.G., Houston M.A., and Augenlicht L.H. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. 54 (1994) 3288-3293
12. Singh B., Halestrap A.P., and Paraskeva C. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis 18 (1997) 1265-1270
13. Barnard J.A., and Warwick G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ. 4 (1993) 495-501
14. Vecchia M.G., Carnelos Filho M., Fellipe C.R., Curi R., and Newsholme E.A. Acetate and propionate potentiate the antiproliferative effect of butyrate on RBL-2H3 growth. Gen. Pharmacol. 29 (1997) 725-728
15. Yamamoto H., Fujimoto J., Okamoto E., Furuvama J., Tamaoki T., and Hashimoto-Yamaoki T. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo. Int. J. Cancer 76 (1998) 897-902
16. Siavoshian S., Segain J.P., Kornprobst M., Bonnet C., Cherbut C., Galmiche J.P., and Blottiere H.M. Butyrate and Trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46 (2000) 507-514
17. Litvak D.A., Evers B.M., Hwang K.O., Hellmich M.R., Ko T.C., and Townsend Jr. C.M. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21 Waf1/Cip1 and p27 Kip1. Surgery 124 (1998) 161-170
18. Mandal M., Adam L., Mendelsohn J., and Kumar R. Nuclear targeting of Bax during apoptosis in human colorectal cancer cells. Oncogene 17 (1998) 999-1007
19. Belakavadi M., Prabhakar B.T., and Salimath B.P. Butyrate-induced proapoptotic and antiangiogenic pathways in EAT cells require activation of CAD and downregulation of VEGF. Biochem. Biophys. Res. Commun. 335 (2005) 993-1001
20. Giuliano M., Lauricella M., Calvaruso G., Carabillo M., Emanuele S., Vento R., and Tesoriere G. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells. Cancer Res. 59 (1999) 5586-5595
21. Hara I., Miyake H., Hara S., Arakawa S., and Kamidono S. Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas mediated cytotoxicity. Int. J. Oncol. 17 (2000) 1213-1218
22. Deng G., Liu G., Hu L., Gum J.R., and Kim Y.S. Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate. Cancer Res. 52 (1992) 3378-3383
23. Kruh J., Tichonicky L., and Defer N. Effect of butyrate on gene expression. In: Binder H.J., Cummings J.H., and Soerge K. (Eds). Short Chain Fatty Acids (1994), Dordrecht, Kluwer 135-147
24. Chou J.Y., and Takahashi S. Control of placental alkaline phosphatase gene expression in HeLa cells: induction of synthesis of prednisolone and sodium butyrate. Biochemistry 26 (1997) 3596-3602
25. Telfer J.F., and Green C.D. Placental alkaline phosphatase activity is inversely related to cell growth rate in HeLa S3 cervical cancer cells. FEBS Lett. 329 (1993) 238-244
26. Cuisset L., Tichonicky L., and Delpect M.A. Protein phosphatase is involved in the inhibition of histone deacetylation by sodium butyrate. Biochem. Biophys. Res. Commun. 246 (1998) 760-764
27. Davido D.J., Richter F., Boxberger F., Stahl A., Menzel T., Luhrs H., Loffler S., Dusel G., Rapp U.R., and Scheppach W. Butyrate and propionate downregulate ERK phosphorylation in HT-29 colon carcinoma cells prior to differentiation. Eur. J. Cancer Prev. 4 (2001) 313-321
28. Jung J.W., Cho S.D., Ahn N.S., Yang S.R., Park J.S., Jo E.H., Hwang J.W., Jung J.Y., Kim S.H., Kang K.S., and Lee Y.S. Ras/MAP kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate. Cancer Lett. 225 (2005) 199-206
29. Schwartz B., Avivi-Green C., and Polak-Charcon S. Sodium butyrate induces retinoblastoma protein dephosphorylation of p16 expression and growth arrest of colon cancer cells. Mol. Cell. Biochem. 188 (1998) 21-30
30. Geladopoulos T.P., Sotiroudis T.G., and Evengelopoulos A.E. A malachite green colorimetric assay for protein phosphatase activity. Anal. Biochem. 192 (1991) 112-116
31. Waisman D.M., Salimath B.P., and Anderson D.J. Isolation and characterization of CAB-63, a novel calcium-binding protein. J. Biol. Chem. 260 (1985) 1652-1660
32. Widlak P. The DEF40/CAD endonuclease and its role in apoptosis. Acta Biochim. Pol. 47 (2000) 1037-1044
33. Fischer E.H., Charbonneau H., and Tonks N.K. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 253 (1991) 401-406
34. McComb R.B., Bowers G.N., and Posen S. Alkaline Phosphatases. In: McComb R.B., Bowers G.N., and Poses S. (Eds) (1979), Plenum Press, New York
35. Chen M.X., McPartlin A.E., Brown L., Chen Y.H., Barker H.M., and Cohen P.T.W. A novel human protein serine/threonine which possesses four tetratricopeptide repeat (TPR) motifs and localizes to the nucleus. EMBO J. 13 (1994) 4278-4290
36. Brown L., Borthwick E.B., and Cohen P.T.W. Drosophila protein phosphatase 5 is encoded by a single gene that is most highly expressed during embryonic development. Biochim. Biophys. Acta 1492 (2000) 470-476
37. 2+ and calmodulin dependent protein phosphatase, probable identity with calcineurin (CaM-BP80). FEBS Letts. 137 (1982) 80-84
38. Ingebritsen T.S., Stewart A.A., and Cohen P. The protein phosphatases involved in cellular regulation. 6. Measurement of type-1 and type-2 protein phosphatases in extracts of mammalian tissues; an assessment of their physiological roles. Eur. J. Biochem. 132 (1983) 297-307
39. Lakshmikuttyamma A., Selvakumar P., Ratan Sharma A., Anderson D.H., and Sharma R.K. In vitro proteolytic degradation of bovine brain calcineurin by m-calpain. Neurosci. Res. 29 (2004) 1913-1921
40. Zeke T., Morrice N., V'Azquez-Martin C., and Cohen T.W. Human protein phosphatase 5 dissociates from heat-shock proteins and is proteolytically activated in response to arachidonic acid and the microtubule-depolymerizing drug nocodazole. Biochem. J. 385 (2005) 45-56
41. Santoro M.F., Annand R.R., Robertson M.M., Peng Y.W., Brady M.J., Mankovich J.A., Hackett M.C., Ghayur T., Walter G., Wong W.W., and Giegel G.A. Regulation of protein phosphatase 2A activity by caspase-3 activity during apoptosis. J. Biol. Chem. 273 (1998) 13119-13128
42. Alvarado-Kristensson M., and Anderson T. Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase-3. J. Biol. Chem. 280 (2005) 6238-6244
43. Dzierzewicz Z., Orchel A., Swierczek-Zieba G., Weglarz L., Stojko J., and Wilczok T. Sodium orthovanadate inhibits apoptosis of rat colonocytes in primary culture. Acta Pol. Pharm. 61 (2004) 86-87
44. Afshari C.A., Kodama S., Bivins H.M., Willard T.B., Fujiki H., and Barrett J.C. Induction of neoplastic progression in Syrian hamster embryo cells treated with protein phosphatase inhibitors. Cancer Res. 53 (1993) 1777-1782
45. Chang S.T., and Yung B.Y.M. Potentiation of sodium butyrate-induced apoptosis by vanadate in human promyelocytic leukemia cell line HL-60. Biochem. Biophys. Res. Commun. 21 (1996) 594-601
46. Cruz T.F., Morgan A., and Min W. In vitro and in vivo antineoplastic effects of orthovanadate. Mol. Cell. Biochem. 153 (1995) 161-166
47. Lund-Johansen F., Frey T., Ledbetter J.A., and Thompson P.A. Apoptosis in hematopoietic cells is associated with an extensive decrease in cellular phosphotyrosine content that can be inhibited by the tyrosine phosphatase antagonist pervanadate. Cytometry 25 (1996) 182-190
48. Totpal K., Agarwal S., and Aggarwal B.B. Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cells. Cancer Res. 52 (1992) 2557-2562
49. Yang C., Chang J., Gorospe M., and Passaniti A. Protein tyrosine phosphatase regulation of endothelial cell apoptosis and differentiation. Cell Growth Differ. 7 (1996) 161-171
50. Ye J., Ding M., Leonard S.S., Robinson V.A., Millecchia L., Zhang X., Castranova V., Vallvathan V., and Shi X. Vanadate induces apoptosis in epidermal JB6P+ cells via hydrogen peroxide-mediated reactions. Mol. Cell. Biochem. 202 (1999) 9-17
51. Choi Y.J., Lim S.Y., Woo J.H., Kim Y.H., Kwon Y.K., Suh S.I., Lee S.H., Choi W.Y., Kim J.G., Lee I.S., Park J.W., and Kwon T.K. Sodium orthovanadate potentiates EGCG-induced apoptosis that is dependent on the ERK pathway. Biochem. Biophys. Res. Commun. 305 (2003) 176-185